Insider · CIK 0001597578

Ruegg Curtis

CIK 0001597578 Name as filed on the most recent filing

Filed as Ruegg Curtis (24)

39 transaction lines · from 24 filings · filed 2014-09-19 to 2016-06-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

39 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-06-13 S, Open-market sale Revance Therapeutics, Inc.RVNC 18,250, disposed Open Form 4 filing 0001209191-16-128066
2016-05-09 S, Open-market sale Revance Therapeutics, Inc.RVNC 16,180, disposed Open Form 4 filing 0001209191-16-119301
2016-04-11 S, Open-market sale Revance Therapeutics, Inc.RVNC 19,110, disposed Open Form 4 filing 0001209191-16-114143
2016-03-07 S, Open-market sale Revance Therapeutics, Inc.RVNC 20,430, disposed Open Form 4 filing 0001209191-16-107456
2016-02-08 S, Open-market sale Revance Therapeutics, Inc.RVNC 18,140, disposed Open Form 4 filing 0001209191-16-097462
2016-01-06 S, Open-market sale Revance Therapeutics, Inc.RVNC 66,120, disposed Open Form 4 filing 0001209191-16-090637
2015-08-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 6 lines 90,990, disposed Open Form 4 filing 0001209191-15-066998
2015-07-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 93,090, disposed Open Form 4 filing 0001209191-15-061951
2015-06-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 100,593, disposed Open Form 4 filing 0001209191-15-055189
2015-06-03 S, Open-market sale Revance Therapeutics, Inc.RVNC 15,000, disposed Open Form 4 filing 0001209191-15-050802
2015-05-18 S, Open-market sale Revance Therapeutics, Inc.RVNC 4 lines 66,747, disposed Open Form 4 filing 0001209191-15-044673
2015-05-15 S, Open-market sale Revance Therapeutics, Inc.RVNC 12,500, disposed Open Form 4 filing 0001209191-15-044673
2015-04-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 2 lines 44,467, disposed Open Form 4 filing 0001209191-15-035361
2015-03-19 S, Open-market sale Revance Therapeutics, Inc.RVNC 10,000, disposed Open Form 4 filing 0001209191-15-028590
2015-03-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 27,915, disposed Open Form 4 filing 0001209191-15-027995
2015-03-09 S, Open-market sale Revance Therapeutics, Inc.RVNC 9,000, disposed Open Form 4 filing 0001209191-15-025334
2015-02-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 2 lines 16,800, disposed Open Form 4 filing 0001209191-15-015645
2015-01-20 S, Open-market sale Revance Therapeutics, Inc.RVNC 17,250, disposed Open Form 4 filing 0001209191-15-005965
2015-01-09 S, Open-market sale Revance Therapeutics, Inc.RVNC 9,000, disposed Open Form 4 filing 0001209191-15-003990
2014-12-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 16,450, disposed Open Form 4 filing 0001209191-14-077080
2014-12-09 S, Open-market sale Revance Therapeutics, Inc.RVNC 9,000, disposed Open Form 4 filing 0001209191-14-074650
2014-11-18 S, Open-market sale Revance Therapeutics, Inc.RVNC 16,000, disposed Open Form 4 filing 0001209191-14-070491
2014-10-28 S, Open-market sale Revance Therapeutics, Inc.RVNC 10,000, disposed Open Form 4 filing 0001209191-14-065460
2014-10-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 2 lines 27,839, disposed Open Form 4 filing 0001209191-14-064188
2014-09-17 S, Open-market sale Revance Therapeutics, Inc.RVNC 4 lines 41,098, disposed Open Form 4 filing 0001209191-14-058913

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 39
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Ruegg Curtis, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001597578

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.